MK-6325 Uses, Dosage, Side Effects and more
MK-6325 is under investigation in clinical trial NCT01329913 (Safety, Pharmacokinetics, and Pharmacodynamics of MK-6325 in Hepatitis C Virus (HCV) Infections (MK-6325-003)).
| Trade Name | MK-6325 |
| Generic | MK-6325 |
| Type | |
| Formula | C42H56N6O9S |
| Weight | Average: 821.0 Monoisotopic: 820.382948581 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
